SCHEMBL3234071

SCHEMBL3234071

CCOc1ccc2c(c1)C(C)(c1cc(CN3CCCC3)ccc1Cl)C(=O)N2S(=O)(=O)c1ccc(C(=O)NC(C)(C)C)cc1OC

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 8/20 0.55
AVPR1B P47901 10/20 0.48
OXTR P30559 8/20 0.48
RAB9A P51151 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
MAPK1 P28482 1/20 0.36
ALDH1A1 P00352 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
KMT2A Q03164 1/20 0.36
CCR3 P51677 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
SSTR5 P35346 1/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3227252 0.90 AVPR1A (0.57) AVPR1AAVPR1BOXTRRAB9AL3MBTL1
SCHEMBL3233637 0.88 AVPR1A (0.55) AVPR1AAVPR1BOXTRLMNASMN1; SMN2
SCHEMBL3230051 0.87 AVPR1A (0.55) AVPR1AAVPR1BOXTRRAB9ALMNA
SCHEMBL3234052 0.87 AVPR1A (0.55) AVPR1AAVPR1BOXTRLMNASMN1; SMN2
SCHEMBL3233606 0.87 AVPR1A (0.55) AVPR1AAVPR1BOXTRRAB9AL3MBTL1
SCHEMBL3237260 0.86 AVPR1A (0.56) AVPR1AAVPR1BOXTRLMNASMN1; SMN2
SCHEMBL3222842 0.86 AVPR1A (0.55) AVPR1AAVPR1BL3MBTL1LMNASMN1; SMN2
SCHEMBL3235137 0.85 AVPR1A (0.57) AVPR1ARAB9AL3MBTL1LMNASMN1; SMN2
SCHEMBL3231628 0.85 AVPR1A (0.53) AVPR1AAVPR1BOXTRRAB9AL3MBTL1
SCHEMBL3238642 0.85 AVPR1A (0.57) AVPR1AAVPR1BOXTRALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097374-B1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY AS SELECTIVE LIGANDS OF V2 VASOPRESSIN RECEPTORS SANOFI AVENTIS (FR) 2010-06-09 EP disclosed
US-20100069384-A1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY SANOFI-AVENTIS (FR) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069384-A1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY AVPR2, AVPR1A, AVPR1B AVPR1A 2/4885AVPR1B 3/4885OXTR 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.